Advertisement
DURECT Corporation

DURECT Corporation (DRRX) Stock Overview

Explore DURECT Corporation’s financial performance, market position, analyst ratings, and future outlook.

DRRXNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.91
$0.02(1.04%)
U.S. Market is Open · 13:48
Advertisement

DURECT Corporation (DRRX)

Meyka AI Score

Z

Key Financials

Market Cap59.3M
P/E Ratio73.47
EPS (TTM)$-0.43
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

DRRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DURECT Corporation (DRRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 73.47 and a market capitalization of 59.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
205.26%
6-Month Change
155.007%
Year-to-Date (YTD) Change
141.53%
1-Year Change
46.92%
3-Year Change
-63.27%
5-Year Change
-90.26%
All-Time (Max) Change
-98.67%

Contact Information

408 777 1417
10260 Bubb Road, Cupertino, CA, 95014-4166

Company Facts

210 Employees
IPO DateSep 28, 2000
CountryUS

Frequently Asked Questions